Products
Back
Products
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Clinical Decision Support Protein Chemistry Service
Workflow & Informatics
Automation Systems DxA 5000 Total Lab Automation DxA 5000 Fit Automation System Advanced Informatics Remisol Advance Middleware Remote Services & Diagnostics
Solutions For
Pioneering Digital Hematology Neurology High Sensitivity Diagnostics Host Response to Infection Cardiovascular Disease IDBV Solutions Diabetes Diagnostics Drug Monitoring & Detection Sepsis
Support
Back
Support
Account Support
Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Search for Software Downloads Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support Access Quality Assurance Programs
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Browse Learning Lab › Learning Lab Login ›
Education & Research
Webinars Posters 3D Virtual Laboratory Showcase
Insights
Clinical Studies & Trends Case Studies Publications
Company
Back
Company
People & Culture
Overview Meet Our Teams Diversity + Inclusion How We Work Innovation
Careers
Job Search › Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Clinical Laboratory Diagnostic Products and Solutions / Immunassay / Access BNP und NT-proBNP Assays / Access-BNP-FAQs

Access BNP Customer FAQs

Frequently asked questions for the Access BNP assay being directly sold by Beckman Coulter to customers

Thank you for advancing patient care with Beckman Coulter solutions. We are committed to providing the highest quality diagnostic solutions for our customers and are delighted to announce that on July 26, 2021, Beckman Coulter secured from Quidel Corporation the exclusive distribution rights of the lab-based B-type Natriuretic Peptide (BNP) assay, which is run on Beckman Coulter analyzers. The assay, branded today under Triage® BNP, will be rebranded going forward as “Access BNP”. As a valued customer, you will now receive BNP product and BNP technical support exclusively from Beckman Coulter or your Beckman Coulter authorized distributor. Based on a country by country schedule, Beckman Coulter and/or its authorized distributors will begin selling of the BNP product to you.

FAQs

Based on the country-by-country schedule Beckman Coulter and/or its authorized distributors will begin selling of the BNP product to customers. The BNP assay will eventually be sold under the brand name Access BNP, replacing lab-based TRIAGE® BNP by Quidel.

Until then, customers will continue to receive lab-based Triage BNP from Quidel until the transition date, at which point customers will receive the lab-based Triage BNP or Access BNP from Beckman Coulter and its authorized distributors. This change is going to be in the background without the customer experiencing any change in product quality, service or delivery. Contracts will be updated by the respective Order Management teams in all countries. The product numbers will not change. For reference, the product numbers are: 98200 (Access BNP Reagent), 98201 (Access BNP Control), and 98202 (Access BNP Calibrator).

To support Beckman Coulter customers so they can receive all their cardiac menu needs directly through one source.
This transition from Quidel to Beckman Coulter is only applicable to the lab-based BNP assay. You should continue to order the Triage POC BNP Assay with your Quidel representative or channel partner.
BNP and NT-proBNP are both guideline-recommended to support HF diagnosis and are considered strong predictors of clinical outcomes in all stages of HF. It has been consistently found that both BNP and NT‐proBNP are elevated in patients with heart failure .1.
As was the case before, Access BNP can be used on the Beckman Coulter Access Family of Immunoassay Systems, including Access 2, DxI 600 and DxI 800.
Beckman Coulter has a comprehensive cardiac menu that includes Access hsTnI, the first FDA-cleared high sensitivity troponin I assay, AccuTnI+3 (Troponin I), CK-MB (Creatine Kinase MB), Myoglobin and Digoxin.
There is no difference. It’s the same product with the same formulation. Beckman Coulter was a partner in the manufacturing of the lab-based BNP assay that was previously sold under the Triage brand by Quidel and is exclusively run on Beckman Coulter analyzers. Now Beckman Coulter will be selling it under its Access brand in line with the rest of its cardiac panel. As a customer, you will receive the same high quality, accurate and reliable product. The specifications remain the same. The time to first result remains the same. The claims remain the same. The only difference will be the product packaging – this will be refreshed with the Beckman Coulter branding under the Access family.
You will order Access BNP directly through your Beckman Coulter sales representative or Beckman Coulter authorized distributor on or after the transition date noted above. Ordering will no longer go through Quidel, but Beckman Coulter. Technical support and billing will occur through Beckman Coulter.
To learn about Access BNP pricing, please discuss with your Beckman Coulter sales representative or Beckman Coulter authorized distributor.
No. Beckman Coulter does not recommend additional validation of the Access BNP assay if you previously validated the Quidel lab-based BNP assay. The Quidel lab-based BNP and Access BNP kits contain the same materials.
The product technical specs and features will be the same as Triage lab-based BNP. You can find more information about the Access BNP assay on our website and in the Instructions for Use (IFU) when Access BNP is available in your region and through your sales representative. In the meantime, you may reference the IFU on Quidel’s website.
Please speak with your local Beckman Coulter sales or customer service representative so that they can connect you with our local technical support team to assist you with the matter at hand.
Nothing. You will continue to order lab- based Quidel Triage BNP through your current channel partner until the transition date noted above. Quidel and Quidel’s channel partners will be sending additional communication notifying you of this change as well. This change is going to be in the background without you experiencing any change in product quality, service or delivery. Your contract will be updated before the transition date noted above and Quidel, Beckman Coulter or both parties will be reaching out to you to execute this update. The product numbers will not change. For reference, the product numbers are: 98200 (Access BNP Reagent), 98201 (Access BNP Control), and 98202 (Access BNP Calibrator).

1 de Lemos J A, McGuire D K, Drazner M H. B‐type natriuretic peptide in cardiovascular disease. Lancet 2003362316–322.This review summarises present knowledge on the physiology of BNP and provides comprehensive data on the diagnostic and therapeutic potential of BNP in patients with heart failure.

 

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.